Diabetes Publish Ahead of Print published online ahead of print May 22, 2003 DOI: 10.2337/diabetes.52.7.1591
Received for publication 27 December 2002
Accepted in revised form 28 April 2003
Magnetic Resonance-Defined Periportal Steatosis Following Intraportal Islet Transplantation. A Functional Footprint of Islet Graft Survival?
James F. Markmann 1 *, Mark Rosen 2 , Evan S. Siegelman 2 , Michael C. Soulen 2 , Shaoping Deng 1 , Clyde F. Barker 1 , and Ali Naji 1
From the
1 Department of Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania and 2 Department of Radiology, University of Pennsylvania Health System, Philadelphia, Pennsylvania
* Address correspondence and reprint requests to James F. Markmann. Email: james.markmann{at}uphs.upenn.edu.
There is growing interest in more widespread application of isolated islet transplantation for the treatment of type 1 diabetes; however, the sequelae of long-term islet residence within the liver are unknown. We report herein a consequence of intraportal islet transplantation, specifically the development of periportal hepatic steatosis apparently induced by the local secretion of insulin within the liver.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Lee, M. Ravazzola, B.-H. Park, Y. K. Bashmakov, L. Orci, and R. H. Unger
Metabolic Mechanisms of Failure of Intraportally Transplanted Pancreatic {beta}-Cells in Rats: Role of Lipotoxicity and Prevention by Leptin
Diabetes,
September 1, 2007;
56(9):
2295 - 2301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Meier, I. Hong-McAtee, R. Galasso, J. D. Veldhuis, A. Moran, B. J. Hering, and P. C. Butler
Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver.
Diabetes,
August 1, 2006;
55(8):
2324 - 2332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Ryan, B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli, N. M. Kneteman, J. R.T. Lakey, and A.M. J. Shapiro
Five-Year Follow-Up After Clinical Islet Transplantation
Diabetes,
July 1, 2005;
54(7):
2060 - 2069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Venturini, E. Angeli, P. Maffi, P. Fiorina, F. Bertuzzi, M. Salvioni, F. De Cobelli, C. Socci, L. Aldrighetti, C. Losio, et al.
Technique, Complications, and Therapeutic Efficacy of Percutaneous Transplantation of Human Pancreatic Islet Cells in Type 1 Diabetes: The Role of US
Radiology,
February 1, 2005;
234(2):
617 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bhargava, P. A. Senior, T. E. Ackerman, E. A. Ryan, B. W. Paty, J. R.T. Lakey, and A.M. J. Shapiro
Prevalence of Hepatic Steatosis After Islet Transplantation and Its Relation to Graft Function
Diabetes,
May 1, 2004;
53(5):
1311 - 1317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Harlan
Gene-Altered Islets for Transplant: Giant Leap or Small Step?
Endocrinology,
February 1, 2004;
145(2):
463 - 466.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|